Drug-eluting stents

Interventional/Surgery

Aug 22, 2008 11:00 EDT

Traditionally, Latin American countries have had lower rates of PCI and DES use compared with Europe and the US. Recorded at SOLACI 2008, Dr Leon leads an information exchange on PCI north and south of the border with Drs Abizaid, Belardi, Echeverri and Lopez-Cuellar.

Interventional/Surgery

Percutaneous treatment of valvular disease

4 COMMENTS - Jun 4, 2008 13:00 EDT

Given the success of PCI, the transcatheter management of cardiac disease has expanded into new frontiers. The area of valvular intervention has rapidly evolved in recent years. Dr Philipp Bonhoeffer, a pioneer in the field, discusses current and future developments in the percutaneous management of valvular disease.

Interventional/Surgery

DES & PCI: The comeback kids

3 COMMENTS - May 28, 2008 10:00 EDT

In March 2008, USA Today proclaimed that "Angioplasty's golden era may be fading." Not so fast, say interventional cardiologists in light of positive data for DES vs BMS, and the efficacy of PCI in complex settings. Drs Hamm, Rothman and Waksman discuss the state of DES/PCI in the US and Europe.

Interventional/Surgery

The economics of DES vs BMS: Balancing restenosis, stent thrombosis and quality of life

May 7, 2008 15:00 EDT

The incremental cost of DES versus BMS is balanced by reduced restenosis and improved quality of life. What level of stent thrombosis tips the scale back in favor of BMS? Join Drs Cohen and Bhatt as they discuss decision analysis data that tackles these questions.

Interventional/Surgery

Update on bioabsorbable stents from ACC 2008

1 COMMENT - Apr 21, 2008 16:20 EDT

Now you see it, now you don't. Could bioabsorbable stents be the answer to late stent thrombosis or will acute recoil and restenosis prove to be their Achilles heel? Eric Topol reviews the data on the bioabsorbable stents in development and gives his opinion on the likelihood of the disappearing stent becoming a reality.

Interventional/Surgery

The FellowShip Series: Late stent thrombosis - a case study panel discussion

4 COMMENTS - Apr 14, 2008 17:30 EDT

Dr Topol leads a case-study based discussion with three Fellows on late stent thrombosis.

Interventional/Surgery

SCAI-ACCi2 2008: What's hot in interventional cardiology?

Apr 9, 2008 09:00 EDT

One year post COURAGE, what's hot in the world of interventional cardiology? Dr Jeffrey Popma gives his take on the top stories from the 2008 ACC and SCAI-ACCi2 scientific sessions.

Interventional/Surgery

Challenging cases: Lower limb intervention

Mar 27, 2008 11:13 EDT

Dr Alan Lumsden walks us through a lower limb percutaneous revascularization procedure, pointing out technical tips and common pitfalls along the way.

Interventional/Surgery

DES 2008: New choices, new era

Jan 21, 2008 12:00 EST

2008 will bring two new DES to the US market. Combined with recent reassuring data on long-term outcomes, will next-generation devices kick-start a comeback for DES? Drs Topol and Teirstein discuss these issues and make predictions for PCI in 2008.

Interventional/Surgery

Challenging Cases: Proximal Tortuosity

Dec 21, 2007 15:00 EST

Watch Ashwin Mehta MD navigate hairpin bends in a challenging case of proximal tortuosity.

Interventional/Surgery

Paving the road to better outcomes: DES safety

Nov 8, 2007 09:40 EST

Does the search for a "safer" stent minimize the need for a more "efficacious" one? Does increasing safety heighten efficacy? Will stent safety be enhanced by longer duration of antiplatelet therapy? Join our esteemed faculty as they debate these questions.

Interventional/Surgery

Coronary and peripheral revascularization: Is there room in the sandbox for everyone?

Oct 30, 2007 12:00 EDT

Who should be receiving coronary PCI? Who should be performing PCI? What are the best strategies - for doctor and patient - regarding management of peripheral arterial occlusions? Join our faculty for a stimulating and thought-provoking conversation regarding these issues.

Interventional/Surgery

Next-generation DES: The future is now

Oct 11, 2007 17:00 EDT

The FDA's Circulatory System Devices Panel hearing on the premarket approval application for the Endeavor stent represents the first regulatory test for DES since last year's safety hearings. The bar been raised for DES; are next-generation devices up to the challenge?

Interventional/Surgery

Who's afraid of DES? The appropriate role for DES and PCI in contemporary practice

Sep 28, 2007 13:58 EDT

Following the late thrombosis scare and the COURAGE and OAT trials, DES sales plummeted and PCI rates fell in the US, yet the response was less dramatic in Europe. Did US physicians panic while their European counterparts kept their cool?

Interventional cardiology

Drug-Eluting Stents — The next chapter

1 COMMENT - Nov 1, 2006 11:00 EST

Drug-eluting stents (DESs) have become state of the art interventional therapy for the treatment of coronary vessel occlusion. To date, over 9 million DES devices have been placed. While DESs are designed to minimize the incidence of restenosis, late stent thrombosis appears to be problematic. This program will present the evolution of DES therapy, define late stent thrombosis, and describe current research that will take us to the next level with DES technology.

CME provider: Medscape.
The drug-eluting stents theme is supported by an independent educational grant from Medtronic, Inc., Daiichi Sankyo, Inc., and Eli Lilly & Co.

View all »

Academic partnership

Academic series

Duke Clinical Medicine Series

2 COMMENTS - Mar 1, 2008 15:50 EST

A series of interactive, evidence-based programs designed to improve the care of patients requiring cardiac catheterization and interventions

	Decrease
	No change
	Increase